Skip to main content

Find Clinical Trials

Home
Conditions
Immunoblastic Lymphadenopathy

Clinical trial condition

Immunoblastic Lymphadenopathy

Explore clinical trials studying Immunoblastic Lymphadenopathy. Study availability and eligibility vary by location and protocol.

192 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Immunoblastic Lymphadenopathy trial results

Completed

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

NCT01147991

Conditions: Burkitt Lymphoma, DNA Virus Infections, Digestive System Diseases, +39 more
Locations: University of Birmingham Birmingham, England, United Kingdom

Royal Marsden - London London, England, United Kingdom

Christie Hospital Manchester, England, United Kingdom

View Trial Details

Completed

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

NCT00006379

Conditions: Amyloidosis, Anemia, Anemia, Refractory, +100 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Quality of Life in Younger Leukemia and Lymphoma Survivors

NCT00956475

Conditions: Anxiety Disorder, Anxiety Disorders, Blast Crisis, +87 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

NCT00661999

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +72 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

NCT00002504

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

Bloomington Hospital Bloomington, Indiana, United States

St. Vincent Hospital and Health Care Center Research Department Indianapolis, Indiana, United States

Bergan Mercy Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

NCT00470405

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

NCT00003331

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Kaplan Cancer Center New York, United States

View Trial Details

Completed

Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer

NCT00003294

Conditions: Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +51 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment

NCT00646139

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +53 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Heparin or Enoxaparin in Patients With Cancer

NCT00004875

Conditions: Burkitt Lymphoma, Cardiovascular Diseases, Chronic Disease, +38 more
Locations: Veterans Affairs Medical Center - Chicago (Lakeside) Chicago, Illinois, United States

Evanston Northwestern Health Care Evanston, Illinois, United States

View Trial Details